Zhang Lab

University of Michigan

Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only

Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●DMFold ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

GLASS

You can:

Go to the GPCR, ligand, or experimental data tables.
Go to the experimental data table for text mining information in PubMed ID column.
Go to the GPCR page and check other ligands which interact with it.
Go to the ligand page and check other GPCRs which it interacts with.
Go back to previous page.

GPCR

Name	Substance-K receptor
Species	Homo sapiens (Human)
Gene	TACR2
Synonym	NK2 receptor Neurokinin A receptor Tachykinin receptor 2 TAC2R Substance K receptor SP-E receptor SKR Neurokinin B receptor NK-2 receptor NKNAR NK-2R [ Show all ]
Disease	Urinary incontinence Pain Unspecified Irritable bowel syndrome with diarrhoea Irritable bowel syndrome Infantile colics; Postoperative ileus Depression; Anxiety Depression; Acute or chronic pain; Anxiety disorders; Urinary incontinence Chronic obstructive pulmonary disease Asthma Anxiety disorder [ Show all ]
Length	398
Amino acid sequence	MGTCDIVTEANISSGPESNTTGITAFSMPSWQLALWATAYLALVLVAVTGNAIVIWIILAHRRMRTVTNYFIVNLALADLCMAAFNAAFNFVYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAADRYMAIVHPFQPRLSAPSTKAVIAGIWLVALALASPQCFYSTVTMDQGATKCVVAWPEDSGGKTLLLYHLVVIALIYFLPLAVMFVAYSVIGLTLWRRAVPGHQAHGANLRHLQAMKKFVKTMVLVVLTFAICWLPYHLYFILGSFQEDIYCHKFIQQVYLALFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWVTPTKEDKLELTPTTSLSTRVNRCHTKETLFMAGDTAPSEATSGEAGRPQDGSGLWFGYGLLAPTKTHVEI
UniProt	P21452
Protein Data Bank	N/A
GPCR-HGmod model	P21452
3D structure model	This predicted structure model is from GPCR-EXP P21452.
BioLiP	N/A
Therapeutic Target Database	T52790
ChEMBL	CHEMBL2327
IUPHAR	361
DrugBank	BE0002222

Ligand

Name	danazol
Molecular formula	C22H27NO2
IUPAC name	(1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-ol
Molecular weight	337.463
Hydrogen bond acceptor	3
Hydrogen bond donor	1
XlogP	3.8
Synonyms	DSSTox_RID_76772 (1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.0;{2,10}.0;{4,8}.0;{14,18}]icosa-4(8),5,9-trien-17-ol HMS2231M08 17.Alpha.-Pregna-2, {4-dien-20-yno[2,3-d]isoxazol-17-ol} MLS001066617 199957-EP2275420A1 NCGC00255335-01 AKOS015961192 Pregna-2,4-dien-20-yno(2,3-d)isoxazol-17-ol,(17alpha)- BDBM50423541 Sanofi Synthelabo Brand ofDanazol CCRIS 6747 SR-05000000445-2 D09IPV WIN 17,757 Danazol-ratiopharm Danol ethynyl(dimethyl)[?]ol 1-ethynyl-2,3,3a,3b,4,5,10,10a,10b,11,12,12a-dodecahydro-10a,12a-dimethyl-1H-Cyclopenta[7,8]phenanthro[3,2-d]isoxazol-1-ol HY-B1029 17a-Pregna-2,4-dien-20-yno[2,3-d]isoxazol-17-ol NC00557 230D885 NSC270916 anatrol Prestwick2_000105 BRD-K48970916-001-03-0 SMR000058321 CHEMBL1479 Tox21_301940 WIN-17757 Danazolum [INN-Latin] Danzol (17a)-Pregna-2,4-dien-20-yno[2,3-d]isoxazol-17-ol HMS2090A22 17-alpha-Pregn-4-en-20-yno(2,3-d)isoxazol-17-ol LS-118524 17\|A-hydroxy-2,4,17\|A-pregnadien-20-yno[2,3-D]isoxazole NCGC00179665-02 AC1Q282K Pregna-2, {4-dien-20-yno[2,3-d]isoxazol-17-ol,} (17.alpha.)- AS-13035 ratiopharm Brand of Danazol CAS-17230-88-5 SR-01000760722-2 Cyclomen W-107864 Danazol [USAN:BAN:INN:JAN] [1,2]oxazolo[4',5':2,3]-17alpha-pregn-4-en-20-yn-17-ol Danogen DSSTox_CID_2880 DTXSID2022880 (1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.0^{2,10}.0^{4,8}.0^{14,18}]icosa-4(8),5,9-trien-17-ol HMS3259M10 17230-88-5 MLS001306473 1H-Cyclopenta[7,8]phenanthro[3,2-d]isoxazole- pregna-2,4-dien-20-yno[2,3-d]isoxazol-17-ol deriv. Norciden Alphapharm Brand of Danazol Prestwick0_000105 Bonzol Sanofi Winthrop Brand of Danazol CHEBI:4315 Tox21_112114 Danatrol WIN 17757 Danazole Danoval GTPL6942 17 alpha-pregna-2,4-dien-20-yno[2,3-D] isoxazol-17 beta-ol Kendrick Brand of Danazol 17alpha-Pregna-2,4-dien-20-yno(2,3-d)isoxazol-17-ol NCGC00164400-01 AC-6836 Optina Antigen Brand of Danazol Prestwick3_000105 BSPBio_000090 SPBio_002029 Chronogyn UNII-N29QWW3BUO Danazol (JAN/USP/INN) Winobanin Danocrine DSSTox_GSID_22880 (1R,3aS,3bR,10aR,10bS,12aS)-1-ethynyl-10a,12a-dimethyl-2,3,3a,3b,4,5,10,10a,10b,11,12,12a-dodecahydro-1H-cyclopenta[7,8]phenanthro[3,2-d]isoxazol-1-ol HMS2095E12 17-alpha-Pregna-2,4-dien-20-yno(2,3-d)isoxazol-17-ol MCULE-5533294331 199957-EP2272825A2 NCGC00179665-04 AC1Q29FD Pregna-2,4-dien-20-yno(2,3-d)isoxazol-17-ol, (17alpha)- BCP11914 Sanofi Brand of Danazol CCG-220105 SR-05000000445 D00289 Win 17, 757 Danazol [USAN:USP:INN:BAN:JAN] Danokrin EINECS 241-270-1 1-Ethynyl-10a,12a-dimethyl-2,3,3a,3b,4,5,10,10a,10b,11,12,12a-dodecahydro-1H-cyclopenta[7,8]phenanthro[3,2-d]isoxazol-1-ol HMS3712E12 17a-Pregna-2,4-dien-20-yne-[2,3-d]isoxazole-17b-ol N29QWW3BUO 2,4,17alpha-Pregnadien-20-yno[2,3-d]-isoxa-zol-17-ol NSC 270916 AN-9615 Prestwick1_000105 BPBio1_000100 SCHEMBL21107 Tox21_112114_1 Danazant Win-17,757 Danazolum Danovaol HMS1568E12 17-alpha-2,4-Pregnadien-20-yno(2,3-d)isoxazol-17-ol Ladogal 17beta-Hydroxy-2,4,17alpha-pregnadien-20-yno[2,3-d]-isoxazole NCGC00179665-01 AC1L1FAD Panacrine API0002209 Prestwick_150 C06938 SR-01000760722 CS-4547 Vasaloc Danazol (JP17/USP/INN) ZINC3881958 Danocrine (TN) DB01406 [ Show all ]
Inchi Key	POZRVZJJTULAOH-LHZXLZLDSA-N
Inchi ID	InChI=1S/C22H27NO2/c1-4-22(24)10-8-18-16-6-5-15-11-19-14(13-23-25-19)12-20(15,2)17(16)7-9-21(18,22)3/h1,11,13,16-18,24H,5-10,12H2,2-3H3/t16-,17+,18+,20+,21+,22+/m1/s1
PubChem CID	28417
ChEMBL	CHEMBL1479
IUPHAR	N/A
BindingDB	N/A
DrugBank	DB01406
Structure SDF download
Lipinski's druglikeness	This ligand satisfies Lipinski's rule of five.

Experimental Data

Parameter	Value	Reference	Database source
IC50	26580.0 nM	DrugMatrix in vitro pharmacology data	ChEMBL
Ki	8860.0 nM	DrugMatrix in vitro pharmacology data	ChEMBL

zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218